NYT Logo

Forecast Of The Day: The New York Times Digital Subscription Revenue

by Trefis Team
What? The New York Times (NYSE:NYT) Digital Subscription Revenue rose from around $460 million in 2019 to about $600 million in 2020. Trefis expects the metric to rise to about $802 million in 2021 and to around $900 million by 2022. Why? Gro...
Read More >   |   Share
NFLX Logo

Company Of The Day: Netflix

by Trefis Team
What? Netflix (NASDAQ:NFLX) is raising pricing on its plans in the U.S. by between $1 to $2. The popular HD plan will see its price increase from $14 per month to $15.50. Why? With subscriber growth in the U.S. cooling, Netflix is banking on ...
Read More >   |   Share
JBLU Logo

Will The Tide Turn For JetBlue Airways Stock?

by Trefis Team
The shares of JetBlue Airways (NASDAQ: JBLU) are trading 30% below pre-Covid levels despite relatively high passenger numbers at TSA checkpoints due to the anticipation of a prolonged dip in air travel demand. However, investors have been optim...
Read More >   |   Share
ADP Logo

Workday Stock Is A Good Pick To Realize Gains

by Trefis Team
 
Read More >   |   Share
PAYX Logo

Should You Book Profits In Paychex Stock Now Or Wait?

by Trefis Team
The shares of Paychex (NASDAQ: PAYX) surged after posting strong Q2 FY2022 numbers last month. However, the stock observed a correction in recent weeks fairly in-line with other stocks including ADP, Paycom, and Workday. Investors had been opti...
Read More >   |   Share
BMY Logo

Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?

by Trefis Team
We think that  Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to Pfizer stock   (NYSE: PFE), given its better growth prospects and comparatively lower valuation of 3.0x trailing revenues, compared to 4.7x for Pfizer....
Read More >   |   Share

Will BeiGene Stock Rebound After A 15% Fall Over The Last Month?

by Trefis Team
The stock price of  BeiGene (NASDAQ: BGNE), a China-based biotechnology company focused on developing molecularly targeted and immuno-oncology drug candidates, has seen a fall of 15% over the last twenty-one trading days, while it is up 5% over t...
Read More >   |   Share
NTAP Logo

Read This If You Think NetApp Stock Is Your Best Cloud Services Bet

by Trefis Team
We think that Nutanix Inc. (NASDAQ:NTNX) currently is a better bet compared to NetApp Inc. (NASDAQ:NTAP) . NTNX stock trades at 4.3x trailing revenues, higher than that of NTAP, whose P/S multiple stands at 3.3x. Does this gap in the companies...
Read More >   |   Share
PFE Logo

Forecast Of The Day: Pfizer’s Oncology Revenue

by Trefis Team
What? Pfizer’s (NYSE:PFE) Oncology Revenue, which includes revenues from Sutent, Xalkori, Inlyta, Ibrance, and other productions, rose from around $9 billion in 2019 to about $11 billion in 2020. We expect the metric to rise to around $12...
Read More >   |   Share
DAL Logo

Company Of The Day: Delta Airlines

by Trefis Team
What? Delta Airlines (NYSE:DAL) reported a better than expected set of Q4 2021 results, with adjusted operating revenues coming in at about $8.4 billion, about 74% of 2019 levels. However, the airline warned that it was likely to post a loss ov...
Read More >   |   Share
ISRG Logo

What’s Happening With Intuitive Surgical Stock?

by Trefis Team
[Updated: Jan 12, 2022] ISRG Stock Decline Last month we discussed that the stock price of Intuitive Surgical (NASDAQ: ISRG) is likely to see higher levels based on the stock’s historical performance, but it appeared to have limited upsi...
Read More >   |   Share
GS Logo

Goldman Sachs Stock To Report Mixed Results In Q4?

by Trefis Team
Goldman Sachs (NYSE: GS) is scheduled to report its fiscal Q4 2021 results on Tuesday, January 18, 2022. We expect Goldman Sachs to report mixed results, with revenues outperforming the consensus estimates and earnings missing the expected figu...
Read More >   |   Share
BK Logo

What To Expect From BNY Mellon Stock In Q4?

by Trefis Team
BNY Mellon (NYSE: BK) is scheduled to report its fiscal Q4 2021 results on Tuesday, January 18, 2022. We expect BNY Mellon to remain marginally below the consensus estimates for revenues and earnings. The custody banking giant posted better tha...
Read More >   |   Share

Will Hess Corporation Stock Continue Higher?

by Trefis Team
The shares of Hess Corporation (NYSE: HES) have observed a strong rally in the past week assisted by the surge in benchmark prices. Hess is an independent exploration and production company with operations in the U.S., Guyana, Malaysia, and Den...
Read More >   |   Share
XOM Logo

Stocks That Benefit From Surging Inflation And The Coming Rate Hikes

by Trefis Team
Inflation in the United States continues to surge with the consumer price index (CPI) published by the Bureau of Labor Statistics rising 7% in December 2021, the largest 12-month increase since June 1982. The inflation metric also rose 0.5% from ...
Read More >   |   Share